56 related articles for article (PubMed ID: 24649229)
21. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
Inohara H; Takenaka Y; Yoshii T; Nakahara S; Yamamoto Y; Tomiyama Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Ogawa K
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):934-41. PubMed ID: 25832686
[TBL] [Abstract][Full Text] [Related]
22. Comparison of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ-preservation modalities in advanced laryngeal squamous cell carcinomas: A multicenter retrospective analysis.
Bussu F; Paludetti G; Almadori G; De Virgilio A; Galli J; Miccichè F; Tombolini M; Rizzo D; Gallo A; Giglia V; Greco A; Valentini V; De Vincentiis M
Head Neck; 2013 Apr; 35(4):554-61. PubMed ID: 22495830
[TBL] [Abstract][Full Text] [Related]
23. A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Won YW; Park YH; Ahn MJ; Do IG; Ko YH; Park K
Ann Oncol; 2011 Feb; 22(2):417-23. PubMed ID: 20696678
[TBL] [Abstract][Full Text] [Related]
24. Role of concurrent chemoradiation in laryngeal preservation for supraglottic cancer.
Yoon TM; Lee JK; Cho JS; Lim SC; Chung WK
J Otolaryngol Head Neck Surg; 2010 Apr; 39(2):142-9. PubMed ID: 20211100
[TBL] [Abstract][Full Text] [Related]
25. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy.
Lefebvre JL; Rolland F; Tesselaar M; Bardet E; Leemans CR; Geoffrois L; Hupperets P; Barzan L; de Raucourt D; Chevalier D; Licitra L; Lunghi F; Stupp R; Lacombe D; Bogaerts J; Horiot JC; Bernier J; Vermorken JB; ;
J Natl Cancer Inst; 2009 Feb; 101(3):142-52. PubMed ID: 19176454
[TBL] [Abstract][Full Text] [Related]
26. Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
Rodriguez CP; Adelstein DJ; Rybicki LA; Saxton JP; Lorenz RR; Wood BG; Strome M; Esclamado RM; Lavertu P; Carroll MA
Head Neck; 2008 Dec; 30(12):1535-42. PubMed ID: 18704968
[TBL] [Abstract][Full Text] [Related]
27. [Concurrent chemoradiotherapy for squamous cell carcinoma of the oropharynx].
Kubota A; Furukawa M; Hanamura H; Fujita Y; Sugiyama M
Nihon Jibiinkoka Gakkai Kaiho; 2007 Sep; 110(9):635-42. PubMed ID: 17966498
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Kim JG; Sohn SK; Kim DH; Baek JH; Jeon SB; Chae YS; Lee KB; Park JS; Sohn JH; Kim JC; Park IK
Br J Cancer; 2005 Nov; 93(10):1117-21. PubMed ID: 16251869
[TBL] [Abstract][Full Text] [Related]
29. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.
Forastiere AA; Goepfert H; Maor M; Pajak TF; Weber R; Morrison W; Glisson B; Trotti A; Ridge JA; Chao C; Peters G; Lee DJ; Leaf A; Ensley J; Cooper J
N Engl J Med; 2003 Nov; 349(22):2091-8. PubMed ID: 14645636
[TBL] [Abstract][Full Text] [Related]
30. Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients.
Pivot X; Chamorey E; Guardiola E; Magné N; Thyss A; Otto J; Giroux B; Mouri Z; Schneider M; Milano G
Ann Oncol; 2003 Oct; 14(10):1578-86. PubMed ID: 14504061
[TBL] [Abstract][Full Text] [Related]
31. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.
Adelstein DJ; Li Y; Adams GL; Wagner H; Kish JA; Ensley JF; Schuller DE; Forastiere AA
J Clin Oncol; 2003 Jan; 21(1):92-8. PubMed ID: 12506176
[TBL] [Abstract][Full Text] [Related]
32. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.
Van Cutsem E; Twelves C; Cassidy J; Allman D; Bajetta E; Boyer M; Bugat R; Findlay M; Frings S; Jahn M; McKendrick J; Osterwalder B; Perez-Manga G; Rosso R; Rougier P; Schmiegel WH; Seitz JF; Thompson P; Vieitez JM; Weitzel C; Harper P;
J Clin Oncol; 2001 Nov; 19(21):4097-106. PubMed ID: 11689577
[TBL] [Abstract][Full Text] [Related]
33. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.
Hoff PM; Ansari R; Batist G; Cox J; Kocha W; Kuperminc M; Maroun J; Walde D; Weaver C; Harrison E; Burger HU; Osterwalder B; Wong AO; Wong R
J Clin Oncol; 2001 Apr; 19(8):2282-92. PubMed ID: 11304782
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.
Pignon JP; Bourhis J; Domenge C; Designé L
Lancet; 2000 Mar; 355(9208):949-55. PubMed ID: 10768432
[TBL] [Abstract][Full Text] [Related]
35. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
Vokes EE; Kies MS; Haraf DJ; Stenson K; List M; Humerickhouse R; Dolan ME; Pelzer H; Sulzen L; Witt ME; Hsieh YC; Mittal BB; Weichselbaum RR
J Clin Oncol; 2000 Apr; 18(8):1652-61. PubMed ID: 10764425
[TBL] [Abstract][Full Text] [Related]
36. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.
Schüller J; Cassidy J; Dumont E; Roos B; Durston S; Banken L; Utoh M; Mori K; Weidekamm E; Reigner B
Cancer Chemother Pharmacol; 2000; 45(4):291-7. PubMed ID: 10755317
[TBL] [Abstract][Full Text] [Related]
37. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts.
Sawada N; Ishikawa T; Sekiguchi F; Tanaka Y; Ishitsuka H
Clin Cancer Res; 1999 Oct; 5(10):2948-53. PubMed ID: 10537364
[TBL] [Abstract][Full Text] [Related]
38. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.
Blum JL; Jones SE; Buzdar AU; LoRusso PM; Kuter I; Vogel C; Osterwalder B; Burger HU; Brown CS; Griffin T
J Clin Oncol; 1999 Feb; 17(2):485-93. PubMed ID: 10080589
[TBL] [Abstract][Full Text] [Related]
39. Randomized trial of induction chemotherapy in larynx carcinoma.
Richard JM; Sancho-Garnier H; Pessey JJ; Luboinski B; Lefebvre JL; Dehesdin D; Stromboni-Luboinski M; Hill C
Oral Oncol; 1998 May; 34(3):224-8. PubMed ID: 9692058
[TBL] [Abstract][Full Text] [Related]
40. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.
Brizel DM; Albers ME; Fisher SR; Scher RL; Richtsmeier WJ; Hars V; George SL; Huang AT; Prosnitz LR
N Engl J Med; 1998 Jun; 338(25):1798-804. PubMed ID: 9632446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
